Patients undergoing autologous breast reconstruction have higher rates of patient reported satisfaction as compared to patients undergoing prosthetic reconstruction. Obesity, defined as body mass index (BMI) ≥30 kg/m 2 , has been shown in microsurgical and implant reconstructions to increase postoperative complications making this population a great reconstructive challenge. With this challenge in mind, the purpose of this investigation was to evaluate the effects of microsurgical breast reconstruction and prosthetic breast reconstruction on patient reported outcomes and quality of life in obese patients.
RESULTS: 114 patients met the inclusion criteria: 41.2 percent (n=47) of patients underwent microsurgical breast reconstruction and 58.8 percent (n=67) underwent tissue expander/ implant reconstruction. Patients in each cohort were similar in BMI, mean mastectomy specimen weight, indication for surgery, smoking status and postoperative complications. However, patients undergoing microsurgical breast reconstruction were younger (48.0 versus 53.0 years, p=0.02), more likely to have bilateral reconstruction (66.0 percent (n=31) versus 40.3 percent (n=27), p=0.007), and more likely to have delayed reconstruction (44.5 percent (n=28) versus 0.0 percent (n=0), p= 0.00001). Of those patients undergoing microsurgical reconstruction, 44.7% (n=21) responded to the BREAST-Q survey, whereas 38.8% (n=26) of patients with implant reconstruction were responders. BREAST-Q responses showed patients undergoing microsurgical breast reconstruction were more satisfied with their breasts (Q-score of 64.1 (25.3) versus 54.6 (21.0), p=0.04) and satisfaction with overall outcome (Q-score 73.5 (25.5) versus 63.5 (25.2), p=0.02). However, both cohorts had similar chest wall physical well-being, sexual well being, and psychosocial well being. Conclusions: Microsurgical breast reconstruction in obese patients yields higher satisfaction with breasts and overall outcomes as compared to implant based reconstruction. Despite increased postoperative complications associated with obese patients, microsurgical breast reconstruction appears to offer a superior reconstructive choice. This information will be important in preoperative patient discussions and counseling. 
PURPOSE:
Complex abdominal wall reconstruction (CAWR) for ventral hernia repair addresses a challenging and morbid patient population. Patients often have multiple prior attempts at hernia repair as well as contaminated or infected wounds. There remains significant disagreement in the surgical community regarding optimal choice of mesh and location of mesh placement, although underlay and permanent mesh has generally been preferred. Beginning several years ago with the arrival of Poly-4-hydroxybutyrate (P4HB) in mesh form, this material has become our preferred mesh used in CAWR. This biosynthetic, degradable polymer retains strength for at least 6 months, the time required for wound healing to reach maximal post injury strength. Because it degrades thereafter, complications associated with permanent synthetic materials are avoided. Further, because it becomes PSRC Abstract Supplement
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rapidly infiltrated with host tissue, it is relatively resistant to infection and is non-seromagenic. Given these appealing characteristics, we have used this mesh in the onlay position, making the placement of the mesh much more efficient. We reviewed our experience using P4HB mesh in CAWR as an onlay in the setting of bilateral component separation.
METHODS:
All patients (n=101) undergoing CAWR between June 2014 and March 2017 at two major university hospitals were followed prospectively. In all cases, surgical repair involved bilateral components separation with elevation of the external oblique laterally to the origin of its segmental vascular supply, followed by primary fascial repair at the midline and P4HB mesh onlay secured to the released lateral edges of the external oblique fascia. Patients were followed up to 38 months.
RESULTS:
101 patients (106 cases; 50 male, 51 female; mean age 59 years, range 22-84) underwent CAWR. Mean BMI was 29 (range 16-48). 56(55%) patients underwent prior repair with an average of 3.5 prior abdominal operations (range 0-12, median 3). 67(66%) patients had at least 2 major medical comorbidities and 77(76%) patients were ASA 3 or greater. 16(15%) were contaminated or infected prior to repair. Average follow up was 15.6 months (range 1-38). 9(8%) patients developed a recurrence at an average of 10.1 months (range 2-18), all of which were appreciably smaller than the original defect. Of the 9 recurrences, 5 were located superiorly and 2 inferiorly to prior mesh placement, 1 in a prior stoma site and 1 in the epigastric midline. 5(5%) patients developed infections treated with antibiotics alone and 6(6%) developed seromas requiring aspiration in the office. Mesh exposure occurred in 8(8%) patients and was treated with local wound care alone in 5 cases. Three patients required operative debridement and re-closure of chronic non-healing wounds; two were found to have retained packing material.
CONCLUSIONS: These data demonstrate an effective, reproducible technique across 2 institutions using a biosynthetic onlay mesh for CAWR with very low rates of hernia recurrence, seroma and other common complications. Notably, no patient developed mesh infection or required mesh excision, even when used in a contaminated surgical field. Although longer follow up is needed, we believe P4HB mesh used as an onlay is a viable option for complex abdominal wall reconstruction. 
PURPOSE:
The deep inferior epigastric perforator (DIEP) flap has become the preferred option for autologous breast reconstruction. Total flap loss can be a devastating morbidity that results in reoperation, increased cost of care, and decreased patient satisfaction. Traditional teaching is that microvascular complications are most likely to occur in the early post-operative period, typically within 48 hours. The purpose of this study was to investigate DIEP total flap loss at our institution. We hypothesized that most of our institution's flap losses occurred in early post-operative period.
METHODS:
A retrospective analysis of patients who underwent DIEP flap breast reconstruction at a single academic institution between January 2015 and July 2017 was performed. Three reconstructive microsurgeons performed all procedures. Pre-operative demographic data including oncologic history and post-operative complications were recorded. Delayed flap loss was defined as non-salvageable flap presenting greater than 48 hours after surgery.
RESULTS:
Eighty-eight patients underwent 137 DIEP flaps for breast reconstruction during the study time-period. Five flaps (3.6%) had threatened flaps due to venous congestion in the first 48 hours post-operatively and three of these were salvaged with emergent operative intervention and anastomotic revision. Five patients suffered total flap loss (3.6%). Sixty percent (3/5) of flap losses occurred after patient discharge (5-6 days post-operatively), with all three patients returning the day after discharge with a non-salvageable flap. All three delayed flap losses were on the left side in patients who underwent bilateral DIEP reconstruction. When patients with early microvascular complications were compared to the delayed flap loss group, there were no significant differences in age, BMI, smoking status,
